Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@PsychedStocks Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1456314648001761285.png) @PsychedStocks PsychedStocks

PsychedStocks posts on X about $cybn, $cmps, $mnmd, $atai the most. They currently have XXX followers and 3822 posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1456314648001761285/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456314648001761285/c:line/m:interactions.svg)

- X Week XXXXXX +19%
- X Month XXXXXX -XX%
- X Months XXXXXXX +20%
- X Year XXXXXXXXX +221%

### Mentions: XX [#](/creator/twitter::1456314648001761285/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456314648001761285/c:line/m:posts_active.svg)

- X Week XXX +12%
- X Month XXX -XX%
- X Months XXXXX +186%
- X Year XXXXX +2,753%

### Followers: XXX [#](/creator/twitter::1456314648001761285/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456314648001761285/c:line/m:followers.svg)

- X Week XXX +1.20%
- X Month XXX +1.60%
- X Months XXX +29%
- X Year XXX +63%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1456314648001761285/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1456314648001761285/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1456314648001761285/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [technology brands](/list/technology-brands)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [currencies](/list/currencies)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[$cybn](/topic/$cybn) #2, [$cmps](/topic/$cmps) #1, [$mnmd](/topic/$mnmd) #3, [$atai](/topic/$atai) #8, [$psyk](/topic/$psyk) #1, [$ftrp](/topic/$ftrp) #1, [$nvda](/topic/$nvda) #1474, [momentum](/topic/momentum) #1960, [$cybhf](/topic/$cybhf) #1, [$cybe](/topic/$cybe) #1

**Top accounts mentioned or mentioned by**
[@insidepharma](/creator/undefined) [@tomilahren](/creator/undefined) [@armanan94013383](/creator/undefined) [@rosie_vibe2](/creator/undefined) [@smallpharma](/creator/undefined) [@cybinincs](/creator/undefined) [@usfda](/creator/undefined) [@cybininc](/creator/undefined) [@pbs](/creator/undefined) [@insidepharmas](/creator/undefined) [@invezzportal](/creator/undefined) [@chad_pumpiano](/creator/undefined) [@iris89775609](/creator/undefined) [@bgeorgl31486](/creator/undefined) [@ameliasmith1210](/creator/undefined) [@pcatoe52821](/creator/undefined) [@chloe1miller](/creator/undefined) [@izlud66](/creator/undefined) [@emily070i](/creator/undefined) [@baseng04412720](/creator/undefined)

**Top assets mentioned**
[ATAI Life Sciences (ATAI)](/topic/$atai) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Fortinet Inc (FTNT)](/topic/$ftnt) [Crowdstrike Holdings Inc (CRWD)](/topic/$crwd) [Palo Alto Networks Inc (PANW)](/topic/$panw) [Advanced Micro Devices (AMD)](/topic/$amd) [Taiwan Semiconductor (TSM)](/topic/$tsm) [Broadcom, Inc. (AVGO)](/topic/$avgo) [Hundred Million (100M)](/topic/$100m) [Zscaler Inc (ZS)](/topic/$zs) [Apple, Inc. (AAPL)](/topic/$aapl) [Microsoft Corp. (MSFT)](/topic/$msft) [Amazon.com, Inc. (AMZN)](/topic/$amzn) [Wheaton Precious Metals Corp. Common Stock (WPM)](/topic/$wpm) [Newmont Corporation (NEM)](/topic/$nem) [Agnico Eagle Mines Ltd. (AEM)](/topic/$aem) [SPDR S&P XXX ETF Trust (SPY)](/topic/$spy) [Spacemesh (SMH)](/topic/$smh) [CyberArk Software Ltd. (CYBR)](/topic/$cybr) [DexCom, Inc. (DXCM)](/topic/$dxcm) [Barrick Gold Corp. (GOLD)](/topic/$gold) [Franco-Nevada Corporation (FNV)](/topic/$fnv) [BigBear.ai Holdings, Inc. (BBAI)](/topic/$bbai) [Palantir (PLTR)](/topic/$pltr) [Metadium (META)](/topic/$meta) [Ziff Davis, Inc. Common Stock (ZD)](/topic/$zd) [ON Semiconductor, Corp. (ON)](/topic/$on)
### Top Social Posts [#](/creator/twitter::1456314648001761285/posts)
---
Top posts by engagements in the last XX hours

"$CYBN CYB003 Phase X depression trial hits enrollment target Dosing completion ahead of anticipated timeline Psychedelic therapies continue gaining regulatory traction $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979176921238806756) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T13:25Z XXX followers, XXX engagements


"$CYBN Q3 results show pathway to profitability Partnership milestone payment received Clinical stage monetization model emerging $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979222171193954356) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T16:25Z XXX followers, XXX engagements


"$SMH Semiconductors see pullback from recent highs Volume nearing 3x daily average activity Leverage magnifying sector volatility $NVDA $AMD $TSM $AVGO"  
[X Link](https://x.com/PsychedStocks/status/1978120216283332767) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T15:26Z XXX followers, XX engagements


"$CYBN CYB004 anxiety trial making steady progress Phase X program actively enrolling patients Advancing therapeutic options in mental health $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978920188859809837) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T20:25Z XXX followers, XXX engagements


"$CYBE $CYBHF New strategic partnership with U.S. resellers Targeting 221K defense firms projected $100M revenue Disrupting with AI compliance and no-budget insurance $CRWD $PANW $FTNT $ZS"  
[X Link](https://x.com/PsychedStocks/status/1978934272640651514) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T21:21Z XXX followers, XX engagements


"$CYBN First patient dosed in CYB005 AUD trial Early-stage alcohol use disorder treatment Innovative addiction therapy approach $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978935402430910563) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T21:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Innovative cybersecurity for SMEs with CMMC solutions $100M revenue growth potential with AI-enabled tech Disrupting defense sector with risk mitigation tools $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979145671627117038) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T11:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins board for defense focus Billion-dollar defense sector opportunity Transforming cyber insurance market $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979160763022319706) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T12:21Z XXX followers, XX engagements


"$CYBN CYB004 Phase X anxiety trial completion announced Key milestone achieved in mental health treatment pathway Expanding therapeutic opportunities in psychedelics $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979161833287156020) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T12:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Innovative AI platform accelerates compliance XX% organizations vulnerable with $10M cost Driving change in SME cybersecurity insurance $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979175851544482187) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T13:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins board enhancing national security stance Targets 140K defense contractors with CMMC compliance Transformative cybersecurity shift for SMEs $CRWD $PANW $FTNT $ZRAN"  
[X Link](https://x.com/PsychedStocks/status/1979190955338027342) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T14:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait bolsters Board strategic focus $1B+ potential addressable market Disrupting U.S. defense with AI cybersecurity $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979206043721662770) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T15:21Z XXX followers, XX engagements


"$CYBN Positive market movement today with $CYBN Investor interest driving upward momentum Psychedelic sector sentiment improving $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979207161352794296) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T15:25Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins Board Targets 221K US defense firms Innovative AI compliance solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979236213887242614) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T17:21Z XXX followers, XX engagements


"$CYBN CYB004 anxiety trial first patient dosed Advancing towards critical Phase X milestone Multiple shots on goal strategy strengthening $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979237248898846904) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T17:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Accepts national security expert Scott Tait to board Targeting 221K US defense firms $1B potential market AI-driven risk mitigation revolutionizing cybersecurity $CRWD $FTNT $CYBR $ZS"  
[X Link](https://x.com/PsychedStocks/status/1979251421166944517) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T18:21Z XXX followers, XX engagements


"$CYBN CYB004 reports positive Phase X anxiety data Strengthens pipeline with promising results Regulatory pathway now clearer for CYB004 $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979252390369841175) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T18:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Drives growth through CMMC compliance High-impact market potential $1B opportunity Disrupting cybersecurity with unique insurance model $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979266438788513983) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T19:21Z XXX followers, XX engagements


"$TLT Long bonds steady amid yield volatility Trading near average volume today Are rates stabilizing in bond markets $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978071360279544053) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T12:12Z XXX followers, XXX engagements


"$TLT Long bonds slightly down after Fed comments Volume reaching double daily average today Active trade management recommended here $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978088190213820860) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T13:19Z XXX followers, XXX engagements


"$TLT Long bonds see slight dip amidst yield changes Volume surge to over 28M shares today Are market players positioning for rate shifts $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978105089534328860) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T14:26Z XXX followers, XXX engagements


"$TLT Long bonds steady amid moderate market activity Volume remains below threshold for major move Monitoring Fed cues for future yield direction $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978121801684140415) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T15:32Z XXX followers, XXX engagements


"$TLT Long bonds in focus after dovish Fed remarks Volume rise signals investor recalibration Triple leverage provides bond market edge $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978138807636517071) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T16:40Z XXX followers, XX engagements


"$SOXX Chip stocks retracting after recent highs Trading volume approaching 2x the average Explore leveraged opportunities in semis $NVDA $TSM $AVGO $AMD"  
[X Link](https://x.com/PsychedStocks/status/1978448807546200432) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T13:12Z XXX followers, XX engagements


"$QQQ Approaching X% move tech driving gains Volume near triple daily average Is this the inflection point for tech bulls $AAPL $MSFT $NVDA $AMZN"  
[X Link](https://x.com/PsychedStocks/status/1978457814684082407) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T13:47Z XXX followers, XX engagements


"$THRM making waves with its innovative temperature-stable medical devices gaining traction in health markets. $AMWL $TMDI $DXCM $QQQ"  
[X Link](https://x.com/PsychedStocks/status/1920447865991684205) [@PsychedStocks](/creator/x/PsychedStocks) 2025-05-08T11:57Z XXX followers, XX engagements


"$XGD $CGMU.TO $CGMD.TO Gold miners pulling back despite stable gold prices Volume aligns with typical trading day activity Opportunity in sector volatility with mining leverage $NEM $AEM $GOLD $WPM"  
[X Link](https://x.com/PsychedStocks/status/1934670857244176642) [@PsychedStocks](/creator/x/PsychedStocks) 2025-06-16T17:54Z XXX followers, XX engagements


"$XGD $CGMU.TO $CGMD.TO Gold miners' rebound on global inflation fears Increased volumes supporting upward trend Opportunity in 3X leveraged gold plays $NEM $AEM $WPM $FNV"  
[X Link](https://x.com/PsychedStocks/status/1934688038065520675) [@PsychedStocks](/creator/x/PsychedStocks) 2025-06-16T19:02Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Psychedelic treatment for depression advancing fast Regulatory momentum building in biotech sector $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1970147458614231091) [@PsychedStocks](/creator/x/PsychedStocks) 2025-09-22T15:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1970570152837009421) [@PsychedStocks](/creator/x/PsychedStocks) 2025-09-23T19:25Z XXX followers, XXX engagements


"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1972653972541321378) [@PsychedStocks](/creator/x/PsychedStocks) 2025-09-29T13:25Z XXX followers, XXX engagements


"$CYBN Trading 3x average volume on strategic news Psychedelic sector momentum driving interest Depression treatment solutions gaining traction $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1972669046324687205) [@PsychedStocks](/creator/x/PsychedStocks) 2025-09-29T14:25Z XXX followers, XXX engagements


"$CYBN FDA grants breakthrough therapy for CYB003 Accelerates psilocybin depression treatment Positioned for pivotal Phase X trial launch $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1972759589725593768) [@PsychedStocks](/creator/x/PsychedStocks) 2025-09-29T20:25Z XXX followers, XXX engagements


"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1973393805941387691) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-01T14:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1973711001531936928) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-02T11:25Z XXX followers, XXX engagements


"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1973726004356010005) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-02T12:25Z XXX followers, XXX engagements


"$CYBN Trading continues positive with a XXXX% gain Investor interest aligned with clinical prospects Sector momentum bolstered by optimism $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1973773270437560644) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-02T15:33Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psilocybin stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1973788266034844099) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-02T16:32Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1973803489139597349) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-02T17:33Z XXX followers, XXX engagements


"$CYBN rumors of acquisition"  
[X Link](https://x.com/PsychedStocks/status/1975322727486792005) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-06T22:10Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975650131769688256) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-07T19:51Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X trial enrolling rapidly First patient successfully dosed in depression study Advancing psilocybin-based treatment potential $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975900766847082912) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T12:27Z XXX followers, XXX engagements


"$CYBN Phase X trial primary endpoint readout positive Significant efficacy improvement with CYB003 Enhances CYBN's position in depression treatment $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975927401201754161) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T14:12Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment complete in depression Major step forward in psilocybin treatment trial Enhances potential for mental health innovation $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975931426567504067) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T14:28Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975950144014041466) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T15:43Z XXX followers, XXX engagements


"$CYBN Q3 cash burn reduced by XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975961656405504186) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T16:29Z XXX followers, XXX engagements


"$CYBN Q3 results show pathway to profitability Partnership milestone payment received Clinical stage monetization model emerging $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1975991344544846019) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T18:27Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976006108692066791) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T19:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X interim data promising Advancements enhance psilocybin's potential Psychedelic treatment landscape evolving $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976022191289274386) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T20:29Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976036207080427574) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T21:25Z XXX followers, XXX engagements


"$CYBN CYBN trading XXX% higher today Anticipation ahead of Q4 financial results Investor confidence in psychedelic milestones $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976262673944707311) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T12:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Depression trial progressing well with strong data Positioned for major regulatory conversations $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976277793668301276) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T13:25Z XXX followers, XX engagements


"$CYBN CYB003 Phase X trial completion announced Preparing for FDA End-of-Phase-2 meeting Advancing psilocybin treatment for depression $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976292940868681762) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T14:25Z XXX followers, XXX engagements


"$CYBN CYBN shares gain XXXX% trading at $XXXX Volume of 170345 indicates increased interest Psychedelic sector sentiment remains positive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976308005554544791) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T15:25Z XXX followers, XX engagements


"$CYBN CYB003 Phase X primary endpoint readout in Q2 2025 CYB003 potential pivotal next-gen depression treatment Clinical-stage biotech investment opportunity $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976323108731572297) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T16:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X data scheduled for Q2 2025 Regulatory prep underway for FDA meeting Progress in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976353266624614516) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T18:25Z XXX followers, XXX engagements


"$CYBN CYB003 interim safety data released early Robust safety profile supports advancing trials Strengthens position in psilocybin therapy race $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976368465519706376) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T19:25Z XXX followers, XXX engagements


"$CYBN Trading at volume spike with sector movement Increased institutional interest in psychedelics Strong market potential for mental health solutions $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976383550732570971) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T20:25Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976625059671261297) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T12:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial hits primary endpoint Significant efficacy data supports upcoming FDA meeting Positioned as leader in psychedelic therapeutics $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976670411807945096) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T15:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976715738325921815) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T18:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976745933082591262) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T20:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X data to be presented at JPM Conference Significant advancement in psilocybin program Elevating biotech investor engagement $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976761006303941054) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T21:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977697135702213028) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T11:25Z XXX followers, XXX engagements


"$CYBN FDA acknowledges CYB003 breakthrough potential Strategic advancement in depression treatment Path towards Phase X trials accelerating $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977712235100180781) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T12:25Z XXX followers, XXX engagements


"$CYBN CYB004 Phase X anxiety trial achieves full enrollment Strengthens multiple shots on goal strategy Psychedelic development gaining momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977727395340722256) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T13:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977742452984328456) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T14:25Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB003 depression trial Progressing toward Phase X milestone data Developing transformative mental health solutions $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977787872716390836) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T17:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment complete Advancing psilocybin in depression treatment Clinical pathway progressing on schedule $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977802838345441782) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T18:25Z XXX followers, XXX engagements


"$CYBN CYB004 anxiety trial Phase X fully enrolled Advancing pipeline with diverse clinical programs Strategic focus on expanding treatment reach $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977817959880941712) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T19:25Z XXX followers, XXX engagements


"$CYBN Psychedelic rally: $CYBN trading 4x average volume Phase X psilocybin trial boosting investor confidence Mental health innovation drawing institutional focus $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977848145192091702) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T21:25Z XXX followers, XXX engagements


"$CYBN Manufacturing partnership boosts CYB003 Scale-up readiness for Phase X confirmed Accelerating path to market $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978074622424654235) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T12:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X interim data promising Psilocybin progressing depression treatment Unlocking potential for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978089727732449389) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T13:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978104902300626953) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T14:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978119936296861838) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T15:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment progressing Patient dosing in depression trial ongoing Psilocybin treatment seeing positive trends $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978135044217516485) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T16:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X trial interim results announced Encouraging safety and efficacy data for depression Regulatory discussions anticipated next quarter $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978150109176086607) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T17:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978180397012856954) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T19:25Z XXX followers, XXX engagements


"$TLT Long bonds climbing on dovish economic signals Volume over 3x weekly average today Leveraged duration plays see increased interest $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978190059426779368) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T20:03Z XXX followers, XXX engagements


"$CYBN CYB003 trial progressing rapidly Phase X depression study XX% enrolled Strong regulatory path for psilocybin therapy $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978195432267231627) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T20:25Z XXX followers, XXX engagements


"$TLT Long bonds rallying after dovish Fed comments Volume surges to 3x daily average Triple leverage enhancing the bond strategy $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978206160621543533) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T21:07Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X interim safety data positive Trial results strengthen regulatory case Psychedelic innovation targets mental health crises $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978210559054012830) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T21:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978421875408519471) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T11:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment surpasses XX% Patient recruitment shows strong trial momentum Psychedelic treatment pipeline advancing rapidly $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978437026262200800) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T12:25Z XXX followers, XXX engagements


"$SOXX Chip stocks rising nearly X% on strong demand Volume nearing 2x the daily average today AI developments fueling semiconductor interest $NVDA $AMD $TSM $ASML"  
[X Link](https://x.com/PsychedStocks/status/1978465702106308909) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T14:19Z XXX followers, XXX engagements


"$TLT Long bonds slightly up on economic concerns Volume aligns with typical trading range Consider leverage as yields shift dynamically $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978467445728760133) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T14:26Z XXX followers, XXX engagements


"$CYBHF easy road to $XX. Collaboration with Dun & Bradstreet serving over X million SMBs working with $NVDA on agentic ai cyber risk mitigation multi million dollar US Gov contracts incoming tight cap structure. Seems inevitable $BBAI $PLTR $SPY"  
[X Link](https://x.com/PsychedStocks/status/1978471868475523086) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T14:43Z XXX followers, XXX engagements


"$QQQ Tech rally as NASDAQ sees gains Approaching 1.5x average volume today Monitor leverage as trends unfold $AAPL $MSFT $NVDA $META"  
[X Link](https://x.com/PsychedStocks/status/1978474751539462278) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T14:55Z XXX followers, XX engagements


"$SPY Slight pullback after broad market rally Volume near record highs in afternoon trade 3X leverage offers active trading potential $MSFT $AAPL $NVDA $AMZN"  
[X Link](https://x.com/PsychedStocks/status/1978477005889794368) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T15:04Z XXX followers, XX engagements


"$CYBN First patient dosed in CYB003 depression trial Positive momentum as trial progresses Psychedelic medicine gaining traction $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978482376150782029) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T15:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment update Patient dosing for depression advancing Therapeutic pipeline continuing momentum $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978497454573023429) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T16:25Z XXX followers, XXX engagements


"$TLT Long bonds nearing resistance levels Volume showing strength with increased activity Triple leverage can magnify these bond movements $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978501662416240739) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T16:42Z XXX followers, XXX engagements


"$SOXX Chip sector rebound on strong earnings forecast Volume surge driving daily gains 3X leverage capturing chip momentum $NVDA $AMD $AVGO $TSM"  
[X Link](https://x.com/PsychedStocks/status/1978504761587478689) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T16:54Z XXX followers, XXX engagements


"$TLT Long bonds selling off post-Fed minutes Volume surging to 2.5x daily average Consider implications in rising rate environment $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978518561531334915) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T17:49Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins board for security boost Targets $1Billion SME market Disrupts defense sector with CMMC solutions $CRWD $PANW $FTNT $ZD"  
[X Link](https://x.com/PsychedStocks/status/1978526544780828877) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T18:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X data readout positive Depression trial achieving significant milestones Investor confidence boosts market sentiment $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978527599514022325) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T18:25Z XXX followers, XXX engagements


"$TLT Long bonds rallying on dovish Fed speak Yields dropping as recession fears build Triple leverage on duration trade $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978535433890939248) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T18:56Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X progressing ahead of schedule Patient dosing accelerating in psilocybin depression trial Regulatory momentum building for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978542860245893375) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T19:25Z XXX followers, XXX engagements


"$TLT Long bonds steady amid dovish Fed stance Volume aligns with average trading flow Leverage on bond duration opportunity $TLT $TMF $TBT $TMV"  
[X Link](https://x.com/PsychedStocks/status/1978555912378781915) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:17Z XXX followers, XXX engagements


"$SOXX Semiconductors facing pressure today Volume approaching triple average levels Opportunity in pullback for leverage traders $NVDA $TSM $AVGO $AMD"  
[X Link](https://x.com/PsychedStocks/status/1978557718836187163) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:24Z XXX followers, XXX engagements


"$CYBN XXX% price gain on surging volume Psychedelic stocks attracting strong interest Depression treatment solutions gaining visibility $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978559052603900145) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T20:30Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board to bolster defense strategies Targeting 140000 US defense contractors Revolutionizing CMMC compliance for SMEs $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978798377589424245) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T12:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X interim safety data positive Shares up nearly X% on clinical progress Psilocybin therapies gaining traction $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978799427126009933) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T12:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Executes major deal with U.S. government Targeting $1B defense market opportunity Transforming SME cybersecurity landscape $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978813449959280987) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T13:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins Board - bolstering defense focus Addressing $1B market opportunity with swift compliance Disrupting cybersecurity with AI-driven solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978828566486798580) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T14:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins board boosting security expertise Targeting 221000 U.S. defense firms Revolutionizing SME cybersecurity with AI $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978858772526145835) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T16:21Z XXX followers, XX engagements


"$CYBE $CYBHF Strategic reseller to US Government boosts sales XX% reduction in vulnerabilities Transforming SME cybersecurity landscape $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978873868077912373) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T17:21Z XXX followers, XX engagements


"$CYBN CYB003 Phase X data readout expected Q2 2025 Psychedelic therapies gaining momentum Investors anticipate regulatory advancements $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975634998087606558) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-07T18:51Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial nearing completion Primary endpoint data readout Q2 2025 Investor anticipation driving sector momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975701600757825886) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-07T23:15Z XXX followers, XXX engagements


"$CYBN 8-K reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness progressing rapidly $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975885770536767890) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T11:27Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1975976124128588122) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-08T17:26Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment on track Psychedelic depression trial progressing well Regulatory approval efforts gaining momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976338232301265071) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T17:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976398557771903156) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-09T21:25Z XXX followers, XXX engagements


"$CYBN CYB004 Phase X fully enrolled for anxiety Expect data readout in Q2 2025 Solid positioning in the mental health sector $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1976609999171293430) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T11:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X primary endpoint data Q2 2025 18-month cash runway extending strategic scope Early-stage sector ripe for transformative advances $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976655242746855440) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T14:25Z XXX followers, XXX engagements


"$CYBN Strong momentum in CYB003 Phase X trial Patient enrollment nearing completion Advancing depression treatment breakthroughs $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976685529962791327) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T16:25Z XXX followers, XXX engagements


"$CYBN 8-K filing reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness timeline accelerating $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1976700681219166457) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-10T17:25Z XXX followers, XXX engagements


"$CYBN CYB004 last patient dosed in anxiety trial Phase X fully enrolled data expected Q2 2025 Strategic focus on regulatory-ready pipeline $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1977772671329821149) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T16:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X depression trial completed Primary endpoint data readout Q2 2025 Psychedelic treatment viability increasing $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1977833033748119563) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-13T20:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X program progresses First patient dosed marking a key milestone Building momentum in psychedelic treatment $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978059505872040440) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T11:25Z XXX followers, XXX engagements


"$SOXX Chip sector moves on semiconductor index loss Volume spike as traders reassess positions 3X leverage in play amid market shifts $NVDA $TSM $AVGO $AMD"  
[X Link](https://x.com/PsychedStocks/status/1978137062290129101) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T16:33Z XXX followers, XXX engagements


"$CYBN CYB003 trial achieves XX% enrollment milestone Progress in psilocybin depression treatment Pivotal data readout expected Q2 2025 $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978165232540192877) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-14T18:25Z XXX followers, XXX engagements


"$CYBN Investor spotlight on rising $CYBN share Approaches X% gain amid sector enthusiasm Key upcoming trial regulatory milestones in view $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978452118311776760) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T13:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X trial initiated ahead of plans Accelerating psilocybin depression program Potential market leadership opportunity $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978572925377634316) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-15T21:25Z XXX followers, XXX engagements


"$CYBN Trading 4x average volume on positive Q3 earnings Efficient capital use extends cash runway XX months Psychedelic market dynamics drive investor interest $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978784324959752435) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T11:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X primary endpoint readout released Data supports advancement to Phase X trials Strengthens position in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978814549697392754) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T13:25Z XXX followers, XXX engagements


"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978829686416289930) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T14:25Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978844800422908082) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T15:25Z XXX followers, XXX engagements


"$CYBN CYB003 enrollment nears XX% completion Psilocybin depression trial gains momentum Positive vibes in psychedelic sector $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978859804371132741) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T16:25Z XXX followers, XXX engagements


"$CYBN Trading stabilizing post market volatility Investor interest in pipeline developments Focus remains on clinical milestones ahead $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1978874930205749393) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T17:25Z XXX followers, XXX engagements


"$CYBE $CYBHF National Security Expert Joins Board Access to 221000 Defense Companies Redefining Cybersecurity with AI Solutions $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978889039638884421) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T18:21Z XXX followers, XX engagements


"$CYBN CYB004 on track with anxiety Phase X Enrollment completion driving progress Path to commercial readiness strengthening $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978890064311562253) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T18:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins board for strategic growth 221K defense and 600K healthcare firms targeted AI-driven platform leads cybersecurity innovation $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978904074218066412) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T19:21Z XXX followers, XX engagements


"$CYBN CYB003 enrollment completion announced Phase X depression trial fully enrolled Psychedelic pipeline advancing towards data $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1978905124589191383) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T19:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Scott Tait joins Board boosting strategic direction Potential $100M annual revenue opportunity Disrupting SME cybersecurity with AI-driven compliance $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1978919192708473266) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-16T20:21Z XXX followers, XX engagements


"$CYBN CYB003 full enrollment in Phase X achieved Depression trial timeline on track for 2025 data Psychedelic therapies advancing FDA milestones $CMPS $MNMD $ATAI $FTRP"  
[X Link](https://x.com/PsychedStocks/status/1979146703287492662) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T11:25Z XXX followers, XXX engagements


"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"  
[X Link](https://x.com/PsychedStocks/status/1979192024596095259) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T14:25Z XXX followers, XXX engagements


"$CYBE $CYBHF Strategic reseller pact with US Govt Driving exponential sales growth Disrupting SME cybersecurity market $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979221141471256609) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T16:21Z XXX followers, XX engagements


"$CYBE $CYBHF National security expert joins board Expanding risk mitigation reach AI-driven compliance transformation $CRWD $PANW $FTNT $NVDA"  
[X Link](https://x.com/PsychedStocks/status/1979281568414806345) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T20:21Z XXX followers, XX engagements


"$CYBE $CYBHF Scott Tait joins Board bolstering security expertise 140K U.S. defense firms meeting quick compliance needs Innovating SMEs' defense with AI solutions $CRWD $FTNT $PANW $ZS"  
[X Link](https://x.com/PsychedStocks/status/1979296663270232521) [@PsychedStocks](/creator/x/PsychedStocks) 2025-10-17T21:21Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PsychedStocks Avatar @PsychedStocks PsychedStocks

PsychedStocks posts on X about $cybn, $cmps, $mnmd, $atai the most. They currently have XXX followers and 3822 posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXXX +19%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +20%
  • X Year XXXXXXXXX +221%

Mentions: XX #

Mentions Line Chart

  • X Week XXX +12%
  • X Month XXX -XX%
  • X Months XXXXX +186%
  • X Year XXXXX +2,753%

Followers: XXX #

Followers Line Chart

  • X Week XXX +1.20%
  • X Month XXX +1.60%
  • X Months XXX +29%
  • X Year XXX +63%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX% technology brands XXXX% cryptocurrencies XXXX% currencies XXXX% exchanges XXXX%

Social topic influence $cybn #2, $cmps #1, $mnmd #3, $atai #8, $psyk #1, $ftrp #1, $nvda #1474, momentum #1960, $cybhf #1, $cybe #1

Top accounts mentioned or mentioned by @insidepharma @tomilahren @armanan94013383 @rosie_vibe2 @smallpharma @cybinincs @usfda @cybininc @pbs @insidepharmas @invezzportal @chad_pumpiano @iris89775609 @bgeorgl31486 @ameliasmith1210 @pcatoe52821 @chloe1miller @izlud66 @emily070i @baseng04412720

Top assets mentioned ATAI Life Sciences (ATAI) NVIDIA Corp. (NVDA) Fortinet Inc (FTNT) Crowdstrike Holdings Inc (CRWD) Palo Alto Networks Inc (PANW) Advanced Micro Devices (AMD) Taiwan Semiconductor (TSM) Broadcom, Inc. (AVGO) Hundred Million (100M) Zscaler Inc (ZS) Apple, Inc. (AAPL) Microsoft Corp. (MSFT) Amazon.com, Inc. (AMZN) Wheaton Precious Metals Corp. Common Stock (WPM) Newmont Corporation (NEM) Agnico Eagle Mines Ltd. (AEM) SPDR S&P XXX ETF Trust (SPY) Spacemesh (SMH) CyberArk Software Ltd. (CYBR) DexCom, Inc. (DXCM) Barrick Gold Corp. (GOLD) Franco-Nevada Corporation (FNV) BigBear.ai Holdings, Inc. (BBAI) Palantir (PLTR) Metadium (META) Ziff Davis, Inc. Common Stock (ZD) ON Semiconductor, Corp. (ON)

Top Social Posts #


Top posts by engagements in the last XX hours

"$CYBN CYB003 Phase X depression trial hits enrollment target Dosing completion ahead of anticipated timeline Psychedelic therapies continue gaining regulatory traction $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-17T13:25Z XXX followers, XXX engagements

"$CYBN Q3 results show pathway to profitability Partnership milestone payment received Clinical stage monetization model emerging $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-17T16:25Z XXX followers, XXX engagements

"$SMH Semiconductors see pullback from recent highs Volume nearing 3x daily average activity Leverage magnifying sector volatility $NVDA $AMD $TSM $AVGO"
X Link @PsychedStocks 2025-10-14T15:26Z XXX followers, XX engagements

"$CYBN CYB004 anxiety trial making steady progress Phase X program actively enrolling patients Advancing therapeutic options in mental health $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T20:25Z XXX followers, XXX engagements

"$CYBE $CYBHF New strategic partnership with U.S. resellers Targeting 221K defense firms projected $100M revenue Disrupting with AI compliance and no-budget insurance $CRWD $PANW $FTNT $ZS"
X Link @PsychedStocks 2025-10-16T21:21Z XXX followers, XX engagements

"$CYBN First patient dosed in CYB005 AUD trial Early-stage alcohol use disorder treatment Innovative addiction therapy approach $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-16T21:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Innovative cybersecurity for SMEs with CMMC solutions $100M revenue growth potential with AI-enabled tech Disrupting defense sector with risk mitigation tools $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T11:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins board for defense focus Billion-dollar defense sector opportunity Transforming cyber insurance market $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T12:21Z XXX followers, XX engagements

"$CYBN CYB004 Phase X anxiety trial completion announced Key milestone achieved in mental health treatment pathway Expanding therapeutic opportunities in psychedelics $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-17T12:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Innovative AI platform accelerates compliance XX% organizations vulnerable with $10M cost Driving change in SME cybersecurity insurance $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T13:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins board enhancing national security stance Targets 140K defense contractors with CMMC compliance Transformative cybersecurity shift for SMEs $CRWD $PANW $FTNT $ZRAN"
X Link @PsychedStocks 2025-10-17T14:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait bolsters Board strategic focus $1B+ potential addressable market Disrupting U.S. defense with AI cybersecurity $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T15:21Z XXX followers, XX engagements

"$CYBN Positive market movement today with $CYBN Investor interest driving upward momentum Psychedelic sector sentiment improving $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-17T15:25Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins Board Targets 221K US defense firms Innovative AI compliance solutions $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T17:21Z XXX followers, XX engagements

"$CYBN CYB004 anxiety trial first patient dosed Advancing towards critical Phase X milestone Multiple shots on goal strategy strengthening $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-17T17:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Accepts national security expert Scott Tait to board Targeting 221K US defense firms $1B potential market AI-driven risk mitigation revolutionizing cybersecurity $CRWD $FTNT $CYBR $ZS"
X Link @PsychedStocks 2025-10-17T18:21Z XXX followers, XX engagements

"$CYBN CYB004 reports positive Phase X anxiety data Strengthens pipeline with promising results Regulatory pathway now clearer for CYB004 $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-17T18:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Drives growth through CMMC compliance High-impact market potential $1B opportunity Disrupting cybersecurity with unique insurance model $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T19:21Z XXX followers, XX engagements

"$TLT Long bonds steady amid yield volatility Trading near average volume today Are rates stabilizing in bond markets $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T12:12Z XXX followers, XXX engagements

"$TLT Long bonds slightly down after Fed comments Volume reaching double daily average today Active trade management recommended here $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T13:19Z XXX followers, XXX engagements

"$TLT Long bonds see slight dip amidst yield changes Volume surge to over 28M shares today Are market players positioning for rate shifts $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T14:26Z XXX followers, XXX engagements

"$TLT Long bonds steady amid moderate market activity Volume remains below threshold for major move Monitoring Fed cues for future yield direction $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T15:32Z XXX followers, XXX engagements

"$TLT Long bonds in focus after dovish Fed remarks Volume rise signals investor recalibration Triple leverage provides bond market edge $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T16:40Z XXX followers, XX engagements

"$SOXX Chip stocks retracting after recent highs Trading volume approaching 2x the average Explore leveraged opportunities in semis $NVDA $TSM $AVGO $AMD"
X Link @PsychedStocks 2025-10-15T13:12Z XXX followers, XX engagements

"$QQQ Approaching X% move tech driving gains Volume near triple daily average Is this the inflection point for tech bulls $AAPL $MSFT $NVDA $AMZN"
X Link @PsychedStocks 2025-10-15T13:47Z XXX followers, XX engagements

"$THRM making waves with its innovative temperature-stable medical devices gaining traction in health markets. $AMWL $TMDI $DXCM $QQQ"
X Link @PsychedStocks 2025-05-08T11:57Z XXX followers, XX engagements

"$XGD $CGMU.TO $CGMD.TO Gold miners pulling back despite stable gold prices Volume aligns with typical trading day activity Opportunity in sector volatility with mining leverage $NEM $AEM $GOLD $WPM"
X Link @PsychedStocks 2025-06-16T17:54Z XXX followers, XX engagements

"$XGD $CGMU.TO $CGMD.TO Gold miners' rebound on global inflation fears Increased volumes supporting upward trend Opportunity in 3X leveraged gold plays $NEM $AEM $WPM $FNV"
X Link @PsychedStocks 2025-06-16T19:02Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Psychedelic treatment for depression advancing fast Regulatory momentum building in biotech sector $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-09-22T15:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-09-23T19:25Z XXX followers, XXX engagements

"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-09-29T13:25Z XXX followers, XXX engagements

"$CYBN Trading 3x average volume on strategic news Psychedelic sector momentum driving interest Depression treatment solutions gaining traction $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-09-29T14:25Z XXX followers, XXX engagements

"$CYBN FDA grants breakthrough therapy for CYB003 Accelerates psilocybin depression treatment Positioned for pivotal Phase X trial launch $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-09-29T20:25Z XXX followers, XXX engagements

"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-01T14:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-02T11:25Z XXX followers, XXX engagements

"$CYBN Q3 cash burn reduced XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-02T12:25Z XXX followers, XXX engagements

"$CYBN Trading continues positive with a XXXX% gain Investor interest aligned with clinical prospects Sector momentum bolstered by optimism $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-02T15:33Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psilocybin stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-02T16:32Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-02T17:33Z XXX followers, XXX engagements

"$CYBN rumors of acquisition"
X Link @PsychedStocks 2025-10-06T22:10Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-07T19:51Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X trial enrolling rapidly First patient successfully dosed in depression study Advancing psilocybin-based treatment potential $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T12:27Z XXX followers, XXX engagements

"$CYBN Phase X trial primary endpoint readout positive Significant efficacy improvement with CYB003 Enhances CYBN's position in depression treatment $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T14:12Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment complete in depression Major step forward in psilocybin treatment trial Enhances potential for mental health innovation $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T14:28Z XXX followers, XXX engagements

"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T15:43Z XXX followers, XXX engagements

"$CYBN Q3 cash burn reduced by XX% to $7.2M 18-month runway extends to Q1 2026 Efficient capital deployment driving value $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-08T16:29Z XXX followers, XXX engagements

"$CYBN Q3 results show pathway to profitability Partnership milestone payment received Clinical stage monetization model emerging $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T18:27Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T19:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X interim data promising Advancements enhance psilocybin's potential Psychedelic treatment landscape evolving $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T20:29Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-08T21:25Z XXX followers, XXX engagements

"$CYBN CYBN trading XXX% higher today Anticipation ahead of Q4 financial results Investor confidence in psychedelic milestones $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-09T12:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Depression trial progressing well with strong data Positioned for major regulatory conversations $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-09T13:25Z XXX followers, XX engagements

"$CYBN CYB003 Phase X trial completion announced Preparing for FDA End-of-Phase-2 meeting Advancing psilocybin treatment for depression $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T14:25Z XXX followers, XXX engagements

"$CYBN CYBN shares gain XXXX% trading at $XXXX Volume of 170345 indicates increased interest Psychedelic sector sentiment remains positive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T15:25Z XXX followers, XX engagements

"$CYBN CYB003 Phase X primary endpoint readout in Q2 2025 CYB003 potential pivotal next-gen depression treatment Clinical-stage biotech investment opportunity $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T16:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X data scheduled for Q2 2025 Regulatory prep underway for FDA meeting Progress in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T18:25Z XXX followers, XXX engagements

"$CYBN CYB003 interim safety data released early Robust safety profile supports advancing trials Strengthens position in psilocybin therapy race $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T19:25Z XXX followers, XXX engagements

"$CYBN Trading at volume spike with sector movement Increased institutional interest in psychedelics Strong market potential for mental health solutions $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-09T20:25Z XXX followers, XXX engagements

"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-10T12:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X depression trial hits primary endpoint Significant efficacy data supports upcoming FDA meeting Positioned as leader in psychedelic therapeutics $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-10T15:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-10T18:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-10T20:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X data to be presented at JPM Conference Significant advancement in psilocybin program Elevating biotech investor engagement $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-10T21:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-13T11:25Z XXX followers, XXX engagements

"$CYBN FDA acknowledges CYB003 breakthrough potential Strategic advancement in depression treatment Path towards Phase X trials accelerating $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-13T12:25Z XXX followers, XXX engagements

"$CYBN CYB004 Phase X anxiety trial achieves full enrollment Strengthens multiple shots on goal strategy Psychedelic development gaining momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-13T13:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-13T14:25Z XXX followers, XXX engagements

"$CYBN First patient dosed in CYB003 depression trial Progressing toward Phase X milestone data Developing transformative mental health solutions $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-13T17:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment complete Advancing psilocybin in depression treatment Clinical pathway progressing on schedule $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-13T18:25Z XXX followers, XXX engagements

"$CYBN CYB004 anxiety trial Phase X fully enrolled Advancing pipeline with diverse clinical programs Strategic focus on expanding treatment reach $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-13T19:25Z XXX followers, XXX engagements

"$CYBN Psychedelic rally: $CYBN trading 4x average volume Phase X psilocybin trial boosting investor confidence Mental health innovation drawing institutional focus $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-13T21:25Z XXX followers, XXX engagements

"$CYBN Manufacturing partnership boosts CYB003 Scale-up readiness for Phase X confirmed Accelerating path to market $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-14T12:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X interim data promising Psilocybin progressing depression treatment Unlocking potential for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-14T13:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T14:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-14T15:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment progressing Patient dosing in depression trial ongoing Psilocybin treatment seeing positive trends $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T16:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X trial interim results announced Encouraging safety and efficacy data for depression Regulatory discussions anticipated next quarter $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T17:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T19:25Z XXX followers, XXX engagements

"$TLT Long bonds climbing on dovish economic signals Volume over 3x weekly average today Leveraged duration plays see increased interest $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T20:03Z XXX followers, XXX engagements

"$CYBN CYB003 trial progressing rapidly Phase X depression study XX% enrolled Strong regulatory path for psilocybin therapy $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T20:25Z XXX followers, XXX engagements

"$TLT Long bonds rallying after dovish Fed comments Volume surges to 3x daily average Triple leverage enhancing the bond strategy $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-14T21:07Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X interim safety data positive Trial results strengthen regulatory case Psychedelic innovation targets mental health crises $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T21:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on sector optimism Psychedelic stocks gaining institutional interest Depression treatment market opportunity massive $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-15T11:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment surpasses XX% Patient recruitment shows strong trial momentum Psychedelic treatment pipeline advancing rapidly $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-15T12:25Z XXX followers, XXX engagements

"$SOXX Chip stocks rising nearly X% on strong demand Volume nearing 2x the daily average today AI developments fueling semiconductor interest $NVDA $AMD $TSM $ASML"
X Link @PsychedStocks 2025-10-15T14:19Z XXX followers, XXX engagements

"$TLT Long bonds slightly up on economic concerns Volume aligns with typical trading range Consider leverage as yields shift dynamically $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-15T14:26Z XXX followers, XXX engagements

"$CYBHF easy road to $XX. Collaboration with Dun & Bradstreet serving over X million SMBs working with $NVDA on agentic ai cyber risk mitigation multi million dollar US Gov contracts incoming tight cap structure. Seems inevitable $BBAI $PLTR $SPY"
X Link @PsychedStocks 2025-10-15T14:43Z XXX followers, XXX engagements

"$QQQ Tech rally as NASDAQ sees gains Approaching 1.5x average volume today Monitor leverage as trends unfold $AAPL $MSFT $NVDA $META"
X Link @PsychedStocks 2025-10-15T14:55Z XXX followers, XX engagements

"$SPY Slight pullback after broad market rally Volume near record highs in afternoon trade 3X leverage offers active trading potential $MSFT $AAPL $NVDA $AMZN"
X Link @PsychedStocks 2025-10-15T15:04Z XXX followers, XX engagements

"$CYBN First patient dosed in CYB003 depression trial Positive momentum as trial progresses Psychedelic medicine gaining traction $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-15T15:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment update Patient dosing for depression advancing Therapeutic pipeline continuing momentum $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-15T16:25Z XXX followers, XXX engagements

"$TLT Long bonds nearing resistance levels Volume showing strength with increased activity Triple leverage can magnify these bond movements $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-15T16:42Z XXX followers, XXX engagements

"$SOXX Chip sector rebound on strong earnings forecast Volume surge driving daily gains 3X leverage capturing chip momentum $NVDA $AMD $AVGO $TSM"
X Link @PsychedStocks 2025-10-15T16:54Z XXX followers, XXX engagements

"$TLT Long bonds selling off post-Fed minutes Volume surging to 2.5x daily average Consider implications in rising rate environment $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-15T17:49Z XXX followers, XXX engagements

"$CYBE $CYBHF Scott Tait joins board for security boost Targets $1Billion SME market Disrupts defense sector with CMMC solutions $CRWD $PANW $FTNT $ZD"
X Link @PsychedStocks 2025-10-15T18:21Z XXX followers, XX engagements

"$CYBN CYB003 Phase X data readout positive Depression trial achieving significant milestones Investor confidence boosts market sentiment $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-15T18:25Z XXX followers, XXX engagements

"$TLT Long bonds rallying on dovish Fed speak Yields dropping as recession fears build Triple leverage on duration trade $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-15T18:56Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X progressing ahead of schedule Patient dosing accelerating in psilocybin depression trial Regulatory momentum building for breakthrough therapy $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-15T19:25Z XXX followers, XXX engagements

"$TLT Long bonds steady amid dovish Fed stance Volume aligns with average trading flow Leverage on bond duration opportunity $TLT $TMF $TBT $TMV"
X Link @PsychedStocks 2025-10-15T20:17Z XXX followers, XXX engagements

"$SOXX Semiconductors facing pressure today Volume approaching triple average levels Opportunity in pullback for leverage traders $NVDA $TSM $AVGO $AMD"
X Link @PsychedStocks 2025-10-15T20:24Z XXX followers, XXX engagements

"$CYBN XXX% price gain on surging volume Psychedelic stocks attracting strong interest Depression treatment solutions gaining visibility $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-15T20:30Z XXX followers, XXX engagements

"$CYBE $CYBHF Scott Tait joins Board to bolster defense strategies Targeting 140000 US defense contractors Revolutionizing CMMC compliance for SMEs $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T12:21Z XXX followers, XX engagements

"$CYBN CYB003 Phase X interim safety data positive Shares up nearly X% on clinical progress Psilocybin therapies gaining traction $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T12:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Executes major deal with U.S. government Targeting $1B defense market opportunity Transforming SME cybersecurity landscape $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T13:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins Board - bolstering defense focus Addressing $1B market opportunity with swift compliance Disrupting cybersecurity with AI-driven solutions $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T14:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins board boosting security expertise Targeting 221000 U.S. defense firms Revolutionizing SME cybersecurity with AI $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T16:21Z XXX followers, XX engagements

"$CYBE $CYBHF Strategic reseller to US Government boosts sales XX% reduction in vulnerabilities Transforming SME cybersecurity landscape $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T17:21Z XXX followers, XX engagements

"$CYBN CYB003 Phase X data readout expected Q2 2025 Psychedelic therapies gaining momentum Investors anticipate regulatory advancements $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-07T18:51Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X depression trial nearing completion Primary endpoint data readout Q2 2025 Investor anticipation driving sector momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-07T23:15Z XXX followers, XXX engagements

"$CYBN 8-K reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness progressing rapidly $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-08T11:27Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-08T17:26Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment on track Psychedelic depression trial progressing well Regulatory approval efforts gaining momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-09T17:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-09T21:25Z XXX followers, XXX engagements

"$CYBN CYB004 Phase X fully enrolled for anxiety Expect data readout in Q2 2025 Solid positioning in the mental health sector $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-10T11:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X primary endpoint data Q2 2025 18-month cash runway extending strategic scope Early-stage sector ripe for transformative advances $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-10T14:25Z XXX followers, XXX engagements

"$CYBN Strong momentum in CYB003 Phase X trial Patient enrollment nearing completion Advancing depression treatment breakthroughs $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-10T16:25Z XXX followers, XXX engagements

"$CYBN 8-K filing reveals manufacturing partnership Scale-up capabilities secured for Phase X Commercial readiness timeline accelerating $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-10T17:25Z XXX followers, XXX engagements

"$CYBN CYB004 last patient dosed in anxiety trial Phase X fully enrolled data expected Q2 2025 Strategic focus on regulatory-ready pipeline $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-13T16:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X depression trial completed Primary endpoint data readout Q2 2025 Psychedelic treatment viability increasing $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-13T20:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X program progresses First patient dosed marking a key milestone Building momentum in psychedelic treatment $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-14T11:25Z XXX followers, XXX engagements

"$SOXX Chip sector moves on semiconductor index loss Volume spike as traders reassess positions 3X leverage in play amid market shifts $NVDA $TSM $AVGO $AMD"
X Link @PsychedStocks 2025-10-14T16:33Z XXX followers, XXX engagements

"$CYBN CYB003 trial achieves XX% enrollment milestone Progress in psilocybin depression treatment Pivotal data readout expected Q2 2025 $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-14T18:25Z XXX followers, XXX engagements

"$CYBN Investor spotlight on rising $CYBN share Approaches X% gain amid sector enthusiasm Key upcoming trial regulatory milestones in view $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-15T13:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X trial initiated ahead of plans Accelerating psilocybin depression program Potential market leadership opportunity $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-15T21:25Z XXX followers, XXX engagements

"$CYBN Trading 4x average volume on positive Q3 earnings Efficient capital use extends cash runway XX months Psychedelic market dynamics drive investor interest $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T11:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X primary endpoint readout released Data supports advancement to Phase X trials Strengthens position in psilocybin depression treatment $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T13:25Z XXX followers, XXX engagements

"$CYBN CYB003 Phase X enrollment ahead of schedule Patient dosing progressing in depression trial Psilocybin pathway gaining regulatory momentum $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-16T14:25Z XXX followers, XXX engagements

"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T15:25Z XXX followers, XXX engagements

"$CYBN CYB003 enrollment nears XX% completion Psilocybin depression trial gains momentum Positive vibes in psychedelic sector $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T16:25Z XXX followers, XXX engagements

"$CYBN Trading stabilizing post market volatility Investor interest in pipeline developments Focus remains on clinical milestones ahead $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-16T17:25Z XXX followers, XXX engagements

"$CYBE $CYBHF National Security Expert Joins Board Access to 221000 Defense Companies Redefining Cybersecurity with AI Solutions $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T18:21Z XXX followers, XX engagements

"$CYBN CYB004 on track with anxiety Phase X Enrollment completion driving progress Path to commercial readiness strengthening $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-16T18:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Scott Tait joins board for strategic growth 221K defense and 600K healthcare firms targeted AI-driven platform leads cybersecurity innovation $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T19:21Z XXX followers, XX engagements

"$CYBN CYB003 enrollment completion announced Phase X depression trial fully enrolled Psychedelic pipeline advancing towards data $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-16T19:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Scott Tait joins Board boosting strategic direction Potential $100M annual revenue opportunity Disrupting SME cybersecurity with AI-driven compliance $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-16T20:21Z XXX followers, XX engagements

"$CYBN CYB003 full enrollment in Phase X achieved Depression trial timeline on track for 2025 data Psychedelic therapies advancing FDA milestones $CMPS $MNMD $ATAI $FTRP"
X Link @PsychedStocks 2025-10-17T11:25Z XXX followers, XXX engagements

"$CYBN First patient dosed in CYB004 anxiety trial Phase X program now fully enrolled Multiple shots on goal strategy advancing $CMPS $MNMD $ATAI $PSYK"
X Link @PsychedStocks 2025-10-17T14:25Z XXX followers, XXX engagements

"$CYBE $CYBHF Strategic reseller pact with US Govt Driving exponential sales growth Disrupting SME cybersecurity market $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T16:21Z XXX followers, XX engagements

"$CYBE $CYBHF National security expert joins board Expanding risk mitigation reach AI-driven compliance transformation $CRWD $PANW $FTNT $NVDA"
X Link @PsychedStocks 2025-10-17T20:21Z XXX followers, XX engagements

"$CYBE $CYBHF Scott Tait joins Board bolstering security expertise 140K U.S. defense firms meeting quick compliance needs Innovating SMEs' defense with AI solutions $CRWD $FTNT $PANW $ZS"
X Link @PsychedStocks 2025-10-17T21:21Z XXX followers, XX engagements

creator/x::PsychedStocks
/creator/x::PsychedStocks